Clinical Trials Directory

Trials / Completed

CompletedNCT05955612

Use of Procalcitonin, a Blood Test to Guide Antibiotic Therapy for Sepsis in Adults

Use of Procalcitonin Point-of-care Test to Guide De-escalation of Empiric Antibiotic Therapy in Adult Patients With Sepsis in a Tertiary Hospital in Bangladesh (PROCALBAN): a Phase 3 Randomised, Controlled, Open-label Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
532 (actual)
Sponsor
University of Oxford · Academic / Other
Sex
All
Age
16 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Trial design: Randomised controlled, two-arm, parallel, clinical trial to assess the efficacy and safety of sequential daily procalcitonin assessments to guide de-escalation of empirical antibiotic therapy in adult patients with sepsis. Trial settings Trial site is Chattogram Medical College Hospital (CMCH), Bangladesh. CMCH is tertiary care hospital with undergraduate and postgraduate teaching facilities. This tertiary hospital receives referrals from urban and rural areas of southern Bangladesh and has basic facilities for intensive care and haemodialysis. Trial Participants: Male or female hospitalised patients, 16-65 years of age, with confirmed or suspected sepsis Patients (Total 532) will be 1:1 randomised to either: * Intervention arm: daily measurement of serum procalcitonin concentrations to guide de-escalation of antibiotics (Intervention arm: 266), or * Control arm: standard of practice to guide de-escalation of antibiotics without procalcitonin assessments (Control arm: 266). Patients will be followed-up until ICU discharge and/or hospital discharge with an additional follow-up at 28 days after discharge. Funder: Wellcome Trust of Great Britain Grant reference number from Wellcome Trust: 220211/A/20/Z

Conditions

Interventions

TypeNameDescription
PROCEDUREProcalcitonin measurementDaily measurement of serum procalcitonin concentrations to guide de-escalation of antibiotics

Timeline

Start date
2023-07-26
Primary completion
2024-06-20
Completion
2024-07-30
First posted
2023-07-21
Last updated
2024-11-26

Locations

1 site across 1 country: Bangladesh

Source: ClinicalTrials.gov record NCT05955612. Inclusion in this directory is not an endorsement.